CLS Holdings USA, Inc. President & COO Andrew Glashow Presents at the Canaccord Genuity 2020 Virtual Cannabis Symposium
CLS Holdings USA (OTCQB:CLSH) presented at the Canaccord Genuity Virtual Cannabis Symposium, showcasing the company's recent operational advancements. President and COO Andrew Glashow highlighted significant progress post-acquisition of Nevada retail and manufacturing subsidiaries. The presentation emphasized the company’s integrated cannabis model, focusing on quality and consistency in product extraction. CLS operates Oasis Cannabis, a leading dispensary in Las Vegas, and plans to expand its market presence. The company also noted potential impacts of COVID-19 on operations and financial results.
- Successful presentation at Canaccord Genuity Virtual Cannabis Symposium enhances visibility.
- Operational changes post-acquisition of Nevada retail and manufacturing subsidiaries signify growth.
- Oasis Cannabis is recognized as a top marijuana retailer, strategically located near the Las Vegas Strip.
- COVID-19 may adversely impact operations, cultivation, processing activities, and financial results.
LAS VEGAS, NV / ACCESSWIRE / October 7, 2020 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH) ("CLS" or the ‘‘Company''), a diversified cannabis company operating as Cannabis Life Sciences, today made available its presentation from the 2020 Canaccord Genuity Virtual Cannabis Symposium.
Presented by President and COO, Andrew Glashow, viewers can learn about the current state of the company directly from its leadership. This presentation also reviews the operational changes made at CLS entities through the summer, and the momentous developments that have taken place since the company's acquisition of its Nevada retail and manufacturing subsidiaries. The Company is honored to have had the opportunity to present at this esteemed conference.
About CLS Holdings USA, Inc.
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. http://www.clsholdingsinc.com.
Twitter: @CLSHoldingsUSA
Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named "Best Dispensary for Pot Pros" by Desert Companion Magazine. In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com
Photo: Oasis Cannabis Dispensary. Las Vegas, NV
Founded in 2017, City Trees is a Nevada-based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees products are available in numerous dispensaries throughout the state of Nevada. https://citytrees.com
Photo: City Trees production facility, Las Vegas, NV
Forward-Looking Statements
This press release contains certain ''forward-looking information'' within the meaning of applicable Canadian securities legislation and ''forward-looking statements'' as that term is defined in the Private Securities Litigation Reform Act of 1995 (collectively, the ''forward-looking statements''). These statements relate to, among other things, the future impact of the COVID-19 virus on our business, the future results of our initiatives to retain our employees and strengthen our relationships with our customers and community during the pandemic, the future effect of our initiatives to expand market share and achieve growth during and following the pandemic, future results of operations and financial performance, anticipated future events, and the effectiveness of our business practices during the pandemic. The continued spread of COVID-19 could have, and in some cases already has had, an adverse impact on our business, operations and financial results, including through disruptions in our cultivation and processing activities, supply chains and sales channels, and retail dispensary operations as well as a deterioration of general economic conditions including a possible national or global recession. Due to the speed with which the COVID-19 situation is developing and the uncertainty of its magnitude, outcome and duration, it is not possible to estimate its impact on our business, operations or financial results; however, the impact could be material. In some cases, you can identify forward looking statements by terminology such as ''may,'' ''might,'' ''will,'' ''should,'' ''intends,'' ''expects,'' ''plans,'' ''goals,'' ''projects,'' ''anticipates,'' ''believes,'' ''estimates,'' ''predicts,'' ''potential,'' or ''continue'' or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA filings with the SEC and on its SEDAR profile at www.sedar.com for additional details.
CONTACT INFORMATION
Corporate:
Chairman and CEO
Jeff Binder
President and COO
Andrew Glashow
888-438-9132
Investor Relations:
investors@clsholdingsinc.com
SOURCE: CLS Holdings USA, Inc.
View source version on accesswire.com:
https://www.accesswire.com/609490/CLS-Holdings-USA-Inc-President-COO-Andrew-Glashow-Presents-at-the-Canaccord-Genuity-2020-Virtual-Cannabis-Symposium
FAQ
What is CLS Holdings USA's stock symbol?
What recent event did CLS Holdings USA participate in?
Who presented for CLS Holdings USA at the symposium?
What challenges does CLS Holdings USA face due to COVID-19?
What strategic expansion plans does CLS Holdings USA have?
